Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2791.2000 -25.60 (-0.91%)

NSE Apr 02, 2026 15:31 PM

52W high on Mar 13, 2026

Volume: 52,986

Ajanta Pharma Ltd.

11 Dec 2024

2791.20

-0.91%

Ajanta Pharma (SELL): No incremental triggers; valuation expensive

Sell: Ajanta Pharma Ltd.

Recommendation Target

BOB Capital Markets Ltd.

At our virtual conference AJP said it is not looking to venture into newer therapies in India in the next 1-2 years due to hefty valuations

Promoters pledged 2.01% of shares in last quarter. Total pledge stands at 17.29% of promoter holdings